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A B S T R A C T  
     Hypertension severely affects the quality and quantity of life of those afflicted with 
the disease.  In most cases where the cause is known, hypertension is due to an 
abnormally high sodium condition; however, the mechanism by which this occurs is 
unknown.  This phenomenon is particularly detrimental to patients considered to be non-
dippers, experiencing no nocturnal dip in blood pressure.  A proposed molecular 
mechanism for the relationship between dipping and sodium concentration involves the 
regulation of the circadian gene Period 1 homolog (Per1) by aldosterone and was studied 
by using chromatin immunoprecipitation (ChIP).  This technique results in an enrichment 
of the chromatin fragments that are bound by the protein of interest, which after 
Polymerase Chain Reaction (PCR), it can be verified whether or not aldosterone directly 
increases the expression of Per1.  Primers were successfully designed for two locations 
within the Per1 gene.  One set was for the -156 glucocorticoid regulatory element (GRE), 
a potential region where the aldosterone receptor binds and a second set to a 3’ was 
designed as a control.  Optimization of the enzymatic shearing conditions was determined 
to be ten minutes.  There were no PCR products for the samples after the complete ChIP 
assay; however, the expected results were obtained for those samples without pre-
clearing of chromatin and antibody treatment.  For future study, samples should be tested 
systematically using PCR to determine in which step the DNA fragments are lost. 
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I N T R O D U C T I O N  
Hypertension & Its Associated Risks  
 Severe headache, altered mental status, fatigue, tinnitus (ringing in the ears), 
dizziness, vision problems, palpitations, hematuria (blood in the urine), confusion, 
shortness of breath and papilledema (swelling of the optic disc) are all signs of 
hypertension, a medical condition referring to chronically elevated blood pressure [1,2,3].  
Unfortunately, a majority of those afflicted with high blood pressure show no preliminary 
signs and are unaware of their condition until it is too late to prevent the adverse side 
effects and associated risks.   
 Normal blood pressure values for a healthy human adult range from 120 to 139 
systolic and between 80 and 89 diastolic [1].  A person with long-term hypertension, with 
values above 140/90mmHg, is at risk for a multitude of adverse side effects, many of 
which are life threatening [2, 3]. Cardiovascular problems include left ventricular 
hypertrophy, an increased chance of both atherosclerosis and arteriosclerosis, myocardial 
infarction, coronary artery disease (CAD), peripheral vascular disease, congestive heart 
failure (CHF) and aortic aneurysm [1].  Additionally, hypertension can result in renal 
failure, an increase of four to six times the chance of experiencing a cerebrovascular 
accident (CVA) and hypertensive retinopathy.  Studies also show that chronic high blood 
pressure can reduce ones ability to think, ability to remember and learning capacity, all of 
are cognitive decline, which can ultimately lead to senile dementia [2].   
 In light of these associated risks it is evident that high blood pressure can 
dramatically shorten one’s life expectancy as well as lessen the quality of living.  
Individuals over the age of fifty with hypertension suffer from seven years more of 
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cardiovascular problems and have a decrease in five years of life expectancy [3]. In 2004, 
it was estimated that approximately seventy-three million Americans, one in four, had 
hypertension (HTN) and close to 55,000 of these cases resulted in death [4].  
Furthermore, 95% of causes of hypertension are still unknown, demonstrating the need 
for continuous research to discover the causes of this disease [1].  Furthermore, 
cardiovascular problems are more prevalent in those who have nocturnal hypertension 
demonstrating the necessity to find a specialized approach to treatment for these 
individuals [6].    
Dipping and Non-Dipping 
 Extensive research shows that in healthy individuals, the rate of sodium 
reabsorption varies throughout the day, with less reabsorption at night causing a 
nocturnal dip in blood volume and, therefore; blood pressure [6].  This observation 
demonstrates that blood pressure exhibits circadian rhythm regulation patterns.  Those 
who fail to dip at night have been classified as “non-dippers” and suffer from a greater 
risk of cardiovascular complications than those with hypertension who still experience a 
dip at night.  The decrease in blood pressure is usually about 10-20% and typically the 
sodium level in the diet is irrelevant [7].  At night, there is naturally a decrease in the 
amount of natriuresis (excretion of sodium), due to lack of urination.  A non-dipper is 
unable to compensate for this change and therefore continues to reabsorb sodium.  
Additionally, a non-dipper’s elevated blood pressure is affected by a high sodium diet 
unlike that of a dipping person who would simply reabsorb less sodium at night.  
Interestingly, a renal transplantation can change one’s status from non-dipper to dipper 
demonstrating the kidney’s extensive control over this circadian rhythm [7].   
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 Since blood pressure elevation during sleep has been linked with a greater 
detrimental effect on cardiovascular health it is important to better understand the 
mechanisms by which sodium reabsorption by circadian rhythm.  Circadian rhythm refers 
to the twenty-four hour biological clock, which is reset by light cues from the 
environment.  The sleep-wake cycle, heart beat, body temperature, hormone secretion 
and renal blood flow are all examples of other rhythmic fluctuations that are influenced 
by the circadian clock [5].   
Hypertension typically refers to elevated arterial blood pressure; which in the 
majority of the known cases, it is a disease of elevated blood sodium concentration [1].  
The amount of sodium in the blood is directly proportional to the amount of water, 
meaning high sodium concentration results in increased blood volume, which ultimately 
causes an elevation in blood pressure.  Therefore, the ability of the kidney to regulate 
sodium levels is crucial in maintaining healthy blood pressure [4].  In order to adequately 
understand this regulation some relevant topics of basic renal physiology are addressed in 
the following section.   
Basic Renal Physiology & Aldosterone’s Role 
 In humans, there are normally two kidneys present, both lying on the outside of 
the peritoneal cavity, one on each side of the vertebral column.  These organs have seven 
main functions: the regulation of water and electrolyte balance, the excretion of 
metabolic waste, excretion of bioactive substances, the regulation of arterial blood 
pressure, erythropoiesis (red blood cell formation), the regulation of Vitamin D 
production and gluconeogenesis (generation of glucose).  
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 As shown in Figure 1, the outermost portion of the kidney is known as the renal 
cortex, which houses the renal tubules (except a portion of the Loop of Henle), blood 
vessels and cortical collecting ducts.  The innermost portion of the kidney is referred to as 
the renal medulla and contains the remaining portions of the Loop of Henle.  Urine 
formation occurs in the nephrons, the functional units that comprise the kidney.   This 
process is divided into three stages; filtration, tubular reabsorption and tubular secretion.  
The process of urine formation is a crucial part of understanding the role of the kidneys in 
maintaining normal blood pressure values [4].   
Filtration refers to the kidneys’ ability to separate water and solutes from the 
blood that then leave the vascular system through the filtration barrier and enter 
Bowman’s space, in the cortical region.  The volume and solute contents in the filtrate 
and the urine ultimately represent two distinct values due to the processes of reabsorption 
and secretion.  During these processes, additional substances are moved in and out of the 
lumen, both with and against their respective concentration gradients [1].   
At the glomerulus, a capillary tuft surrounded by Bowman’s capsule in the 
nephron, there is a high pressure gradient that causes the serum portion of the blood to be 
forced into the renal tubules.  The direction of flow is through the proximal convoluted 
tubule (PCT), the Loop of Henle, the distal convoluted tubule (DCT) until finally the 
serum leaves the kidney by means of the collecting duct, where the adrenal cortical 
hormone aldosterone has its effect. 
Aldosterone is a steroid hormone in the mineralocorticoid family produced by the 
adrenal cortex.  This hormone reduces sodium excretion by stimulating its reabsorption in 
the renal tubules, with its target epithelium of action being the collecting duct [1].  The 
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signaling pathway of aldosterone is characteristic of a hormone-dependent gene 
activation mechanism.  In the absence of aldosterone the hormone receptor remains in the 
cytoplasm; however, in the presence of aldosterone an activated hormone-receptor 
complex is formed and enter the nucleus.  The complex then binds to a promoter element 
that causes the transcription of mRNA, which encodes for a number of proteins important 
for sodium reabsorption [5].   
 When examining sodium levels specifically, it is apparent that the amount 
excreted is only a very small fraction of what was originally filtered due to reabsorption.  
This active process occurs in all tubular segments of the kidney except the descending 
limb of the loop of Henle.  The remaining segments of the nephron, shown in Figure 1, 
reabsorb varying amounts of sodium as follows: 65% in the proximal tubule, 25% in the 
ascending limb of Henle’s loop, 5% in the distal convoluted tubule and 4-5% in the 
collecting duct, with the latter being stimulated by aldosterone [1].  
 
Figure 1- The Kidney & The Nephron [10].  Part A of this figure shows a cross section 
of the kidney with the cortex covering the internal medulla, while B depicts the nephron, 
where the regulation of the concentration of water and soluble substances is performed.  
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While 98% of the filtered sodium is returned to the body by a variety of 
mechanisms, approximately 2% of sodium reabsorption is dependent on the 
concentration of the aldosterone.  This last 2% is critical for the regulation of blood 
volume and blood pressure.  Because of this, aldosterone is called the “all-purpose 
stimulator of sodium retention” [5].  Aldosterone stimulates renal reabsorption of salt 
which causes a transient positive fluid balance to maintain normal blood volume.  Thus, 
if sodium intake is low, aldosterone cells increase so that the body can better maintain a 
normal sodium water balance by reabsorbing the additional 2% of filtered sodium.  
Conversely, after eating a meal high in sodium, aldosterone release is inhibited, causing a 
decrease in sodium reabsorption.  In the absence of aldosterone a person would excrete 
the 2% filtered sodium, which is roughly an extra thirty grams of sodium chloride a day.  
While this seems to be a small percentage, the volume of the glomerular filtrate is so 
large that the fine regulation of this 2% within the minimal and maximal concentration of 
aldosterone can make drastic changes in ones blood pressure. Because of the direct 
relationship between sodium concentration, blood volume, and blood pressure under 
physiological conditions aldosterone plays an necessary role in both cardiovascular and 
renal health [5].  Already, studies have shown that aldosterone blockades in patients with 
high blood pressure can reduce both mortality rates and the amount of hospitalization.  
Additionally, these patients experienced a reduction of proteinuria, healing of vascular 
and glomerular lesions and the reduction of fibrosis [8].         
Importance of Research Project 
The recent discovery of early aldosterone-responsive transcripts through 
microarray analysis includes Period homolog 1 (Per1), a known circadian rhythm protein 
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[11].  This finding was the first step in identifying a link between these two important 
regulators of blood pressure.  Studies performed by Gumz et al. demonstrated early 
upregulation of Per1 expression after only one hour of aldosterone treatment in a mouse 
inner medullary collecting duct cell line, mIMCD-3 [11].  It is the goal of this research 
project to further investigate the link between aldosterone and Per1 in order to determine 
whether the molecular mechanism responsible for this link is a direct effect of the 
mineralocorticoid aldosterone regulator binding to the promoter region.   
The effects of hypertension can be drastic and greatly diminish both the quality 
and quantity of life.  Moreover, the effects of hypertension are exacerbated by the non-
dipping of blood pressure at night.  Preliminary findings suggest a novel pathway for the 
regulation of dipping of blood pressure at night that involves aldosterone, a hormone 
associated with virtually all cases of inherited hypertension [11].  This mechanism 
involves the regulation of the circadian rhythm gene Period 1 (Per1), which could play a 
role in regulating the dipping of blood pressure during night.  Since the upregulation of 
Per1 has been shown to be regulated by aldosterone, this could be a new mechanism to 
explain the circadian rhythm associated with blood pressure.  Understanding this newly 
proposed mechanism of regulation for Per1 could reshape the current approach to 
treating the millions of cases of idiopathic hypertension, specifically for non-dippers.    
This project has been carried out in collaboration with Dr. Michelle Gumz, a 
postdoctoral fellow in the laboratory of Dr. Charles Wingo.  The Wingo Laboratory is 
located in the Department of Medicine, Division of Nephrology, Hypertension, and Renal 
Transplantation at the University of Florida’s College of Medicine.  The larger research 
project involves multiple objectives including: the characterization of the induction of 
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Per1 by aldosterone, defining the roles of the mineralocorticoid receptor (MR) and the 
glucocorticoid receptor (GR) in aldosterone-mediated regulation of Per1, and the 
characterization of the role of Per1 in the aldosterone-mediated regulation of Na+ 
transport [12].   The specific aim of this proposed project is to determine the molecular 
mechanism by which aldosterone leads to the induction of Per1 in cultured inner 
medullary collecting duct (mIMCD-3) cells. It is hypothesized that the aldosterone-
receptor complex will bind to the promoter element of the Per1gene because early 
upregulation occurs after only one hour of aldosterone treatment.   
To satisfy this objective, chromatin immunoprecipitation (ChIP) was performed, 
which results in an enrichment of the chromatin fragments that are bound by the protein 
of interest.  Better understanding the role of aldosterone in the regulation of dipping and 
non-dipping could lead to a more effective treatment for many who suffer from the 
adverse effects of hypertension.  
9 
M E T H O D S 
This research project was performed at the University of Mary Washington 
(UMW) Jepson Science Center in Fredericksburg, Virginia.  The study was carried out 
under the guidance of Faculty Advisor Dr. Deborah Zies. 
Experimental Design 
    Discovering whether or not the aldosterone receptor binds to the Per1 promoter 
is fundamental to the basic understanding of the molecular mechanism of aldosterone 
regulation of hypertension.  Chromatin immunoprecipitation (ChIP) is one method by 
which these protein-DNA interactions can be assayed [9].  This technique monitors 
protein-nucleic acid interactions by using antibodies specific for the protein of interest.  
For this overall project the following antibodies would each provide necessary 
information because of their specialized function: MR1 (mineralocorticoid receptor), 
GR1 (glucocorticoid receptor), mK4H3 (dimethyl-lysine 4-histone 3), SRC1 (steroid 
receptor coactivator-1) and lastly, Pol II (RNA polymerase II) [12].  GR1 serves as the 
transcription factor that mediates the effect of glucocorticoids, while MR1 is the 
aldosterone receptor.  In order to begin this study, anti-RNA polymerase II antibody was 
used for the antibody treatment.  Pol II mediates transcription which is also expected to 
be present at any active promoter and was the chosen antibody treatment for the ChIP 
assay.   
Primer Design 
The three strongest putative hormone responsive elements (HREs) were 
previously determined to be at –996,-556 and -156 in the Per1 promoter region.  For the 
purposes of this project the putative -156 glucocorticoid response element (GRE) was 
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selected [11].  In order to discover whether or not aldosterone binds to the putative -156 
(GRE) element in the Per1 promoter in order to regulate expression at the transcriptional 
level, two sets of uniquely designed primers were created using the FASTPCR program.  
One set was designed to amplify the putative promoter element and one set was a 
downstream set designed to amplify as a control.  These primers were tested for 
specificity and function on both pMLG107 (containing the promoter region) and pPer1 
(containing the downstream region) plasmids.  In order to have primers optimal for ChIP, 
the following criteria was used: 20-24 nucleotides, melting temperature between 58-60ºC, 
a guanine-cytosine ratio of 40-70%, and a final product of 150-250 base pairs [12].   Two 
sets of primer oligonucleotides were synthesized by SIGMA-GENOSYS.  The first set, 
Set 3, amplifies a potential region where the aldosterone receptor binds, in pMLG107 and 
is shown in Figure 2.  Primer Set 6 was also created for the negative control using the 
cDNA sequence for Mus musculus Per1 (accession number: AF022992). In addition to 
the aforementioned criteria, primers for set six were selected based on the furthest 
possible distance from set three to best ensure that shearing would separate this region 
from the putative binding element. 
 
Figure 2 - Designing Primers for Per1.  The arrow in purple represents the genomic 
sequence surrounding the Per1 gene, while the gene itself is highlighted in orange.  
Primer sets 3 and 6 are denoted in red and green respectively.  Putative hormone 
responsive elements (HREs) are indicated by yellow rectangles.  Numbering is relative to 
the approximate transcription start site (+1).  Set 3 primers were designed for the -156 
putative binding element in order to see if aldosterone binds to the receptor.  Set 6 
primers were designed for a downstream region.  
-556 -996 +1 +1000 
Per1 gene 
Potential glucocoricoid/mineralcorticoid 
(GRE/MRE binding sites) 
Set 6 
Set 3 
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Testing ChIP Primers 
Plasmid Constructs -Transformation.  In order to amplify the amount of plasmids, 
pMLG107 and pPer1, available for polymerase chain reaction (PCR) and testing of the 
primer design, transformation was performed using the DH5α subcloning efficiency 
competent cells procedure (Invitrogen Inc.).  Previously frozen cells were thawed on ice 
and then mixed with 5 µL of the respective plasmids.  After thirty minutes of incubation 
on ice, a twenty second heat shock at 42ºC was performed.  Tubes were then placed on 
ice for two minutes and 950 µL of LB-AMP media.  Tubes were then incubated at 37ºC 
for one hour at 225 rpm.  Approximately, 200 µL of each transformation was plated on 
prewarmed plates and finally incubated overnight at 37ºC.              
Plasmid DNA Purification.  Using the QIAPREP spin kit (Qiagen, Inc.), DNA 
purification was performed in order to extract the DNA from the cells in its pure form.  
After plates were allowed to incubate overnight, two colonies from each were transferred 
into their own respective vials with 3 mL of LB-AMP and placed in a shaker overnight at 
37ºC.  The bacteria were spun in a microcentifuge for one minute at 10,000 rpm.  The 
supernatant was discarded and after repeating this last step the pellet was resuspended in 
P1 resuspensionbuffer.  Next, 250 uL of P2 lysis buffer was added and mixed thoroughly 
through inversion.  Then, 350 uL of N3 neutralization buffer was added and also mixed 
through inversion.  After centrifugation for ten minutes at 13,000 rpm the supernatant 
was decanted into a QIAPREP spin column.  The column was washed successively with 
PB and PE wash buffers and centrifuged with each wash for 30-60.  Lastly, the 
QIAPREP column was placed in a 1.5 mL microcentifuge tube and spun for one minute 
with 50 µL of elution buffer to elute the plasmid DNA for collection. 
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Spectrophotomeric Analysis.  In order to determine the DNA concentration and 
purity a spectrophotometric analysis was performed.  The DNA samples were prepared in 
duplicate, 2 µl of each diluted with 50 µl of DI water.  The absorbances for 260nm and 
280nm wavelengths were obtained.       
Restriction Enzyme Digest.  The restriction enzyme digest was performed in order 
to confirm that the DNA isolated from the DH5α was in fact pMLG107 and pPer1.  For 
the pPer1 plasmid, SalI was used, which cuts the Per1 insert at base pair 4 and 
pcmvsport6 at base pair one-hundred and twenty.  BamHI and HindIII were used for 
pMLG107, which cut at base pairs 374, 2004 and 53, 595 respectively.  Following the 
Promega procedure the following reagents were used in setting up the digest: 2 µl of 10X 
RE buffer, 0.2 µl of acetylated BSA, 1 µL of DNA, 16.3 µL of DI water, and 0.5 µL of 
RE enzyme in order to make a total volume of 20 µL.  Restrictions were mixed and 
incubated at 37ºC for one and a half hours.   
Agarose Gel Electrophoresis.  Gel electrophoresis was performed to separate 
DNA fragments based on size in order determine if the predicted products were obtained 
from the restriction digest.  Agarose powder (0.6 g) was mixed with 60 mL of 1XTAE 
buffer and 6 µL of Gel Red and then heated by microwave for one minute.  After 
allowing to cool to approximately 50ºC, the gel was poured into a plate with a well comb 
and then left to solidify. A 5 µL aliquot of a 200bp ladder marker was used in addition to 
24 µL of each of the plasmid samples, previously combined with 4 µl of gel loading dye.     
PCR Reactions.  Polymerase chain reaction was used to amplify the pMLG and 
pPer1 plasmids using their respective primers and then gel electrophoresis was performed 
in order to confirm that the predicted sizes were created.  PCR reaction volumes were 
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optimized according to the directions specified by the Wingo Laboratory at the 
University of Florida’s College of Medicine [12].  Set up for the components of the 
master mix for PCR analysis is shown in Table 1.  For each reaction tube 1 µL of DNA 
was added.      
Table 1 - PCR Components   
Reagent 1x reaction  
10mM dNTP mix 0.2mM 
 10uM Forward Primer 0.2uM 
10uM Reverse Primer 0.2uM 
Go Taq 1.25 units 
PCR 5x Buffer 1X 
25mM MgCl2 1mM 
Total: 49 µl 
 
PCR Cycle Conditions.  Conventional PCR was performed using MJ Research 
PTC-200 (Peltier thermocycler) DNA Engine Thermal Cycler PCR.  Cycle temperatures 
were used as outlined by Dr. Gumz [12].  Initial denaturation was at 95ºC for 15 minutes, 
followed by 35 cycles of denaturing at 95ºC for 30 seconds, annealing at 55ºC for 30 
seconds, and extension at 72ºC for 30 seconds.  Final extension was at 72ºC for 10 
minutes.  To visualize PCR products reactions were electrophorized at 100V on 1% 
agarose gels stained with Gel Red.   
Chromatin Immunoprecipiation (ChIP) 
 The following procedures were previously outlined in the Active Motif  
ChIP-ITTM kit & Shearing Kit.   
Tissue Culture and Conditions.  In order to analyze the effect of aldosterone 
treatment, chromatin was isolated from both treated and untreated inner medulary 
collecting duct (IMCD-3) cells grown to 70-80% confluency.   Dulbecco’s Modified 
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Eagle Medium nutrient mixture with F-12 (DMEM/F12) plus 10% fetal bovine serum was 
used. 
 IMCD-3 cells were grown on a 10 cm plate with 12 mL of the previously 
prepared DMEM F12 media and 120 µL antibiotic/antimycotic at 37ºC.  After cells were 
grown to 70-80% confluency they were split onto six plates using phosphate buffered 
saline (PBS) as a wash and 1 mL of trypsin, followed by five minute incubation at 37ºC.   
ChIP Overview. During chromatin immunoprecipitation (ChIP), protein and DNA 
interactions are fixed using a formaldehyde treatment, then genomic DNA is isolated and 
sheared with an enzyme shearing cocktail solution.  The sheared DNA is mixed with an 
antibody specific to proteins expected be bound to the promoter of interest.  The 
antibody/protein/DNA complex is then precipitated using a G protein bead that 
recognizes the non-specific portion of the antibody.  After reverse cross-linking and 
treatment with proteinase K, the DNA is purified and it can be analyzed using PCR with 
the primers previously described.  The results can be visualized using gel electrophoresis. 
Optimization of Chromatin Shearing - Enzymatic 
Overview.  DNA shearing was performed through enzymatic digestion.  The 
following procedure was adapted from ChIP-IT chromatin immunoprecipiation kit and 
shearing kit (Active Motif, Inc.).  In order to analyze the shearing efficiency and 
determine the proper amount of incubation time with the enzymatic shearing cocktail cell 
fixation, chromatin isolation and shearing was performed without adding 
phenylmethanesulphonylfluoride (PMSF) or protease inhibitors in order to maximize the 
number of shearing reactions that can be performed.   
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Cell Fixation. By treating cells with a formaldehyde fixation solution a cross-
linking of DNA to any bound proteins occurs.  After cells were allowed to grow to 70-
80% confluency, on three separate 10 cm plates, the cells were harvested using a fixation 
solution, ice-cold 1x PBS, glycine stop-fix solution and cell scraping solutions.   
 After the medium was poured off of the three plates, 7.5 mL of the fixation 
solution (1.22 mL 37% formaldehyde and 30 mL Minimum Essential Medium) was 
added to each and then incubated on a shaking platform for 10 minutes.  Next, the 
fixation solution was poured off and the plates were washed with 5 mL of ice-cold PBS 
(3.5 mL of 10x PBS and 47 mL of dH2O) for 5 seconds.  In order to stop the fixation 
reaction, 3.75 mL of glycine stop-fix solution (2.25 mL of 10x glycine buffer, 2.25 mL of 
10x PBS and 18 mL of dH2O) was added to each of the plates and rocked back and forth 
to cover the entire plate.  Incubation and rocking was performed for 5 seconds at room 
temperature.  The glycine stop-fix solution was poured off and the plates were again 
washed with 5 mL of ice-cold PBS for 5 seconds followed by the addition of 750 µL of 
cell scraping solution (450 µL PBS, and 4.0 mL of dH2O) to each of the plates.  The 
plates were held at an angle and scraped downwards using a rubber policeman so that 
they could be collected at the bottom of the plate.  The cells from the three plates were 
collected in a 15 mL conical tube for centrifugation at 2500 rpm (720 RCF) at 4ºC.  The 
supernatant was removed and the cell pellet was either be stored at -80ºC or sheared.             
Chromatin Isolation and Shearing.  The cells were lysed and the resulting DNA-
protein complexes were sheared to cut the DNA into small enough fragments so that the 
potential putative binding elements would each be part of their own discrete units.  This 
was performed by resuspending the pellet in 1mL of lysis buffer.  Cells were transferred 
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into an ice-cold 2 mL dounce homogenizer, shown in Figure 3, and dounced gently on ice 
with 10 strokes to aid in nuclei release.  This apparatus is distinct from other 
homogenizers because its tight-fitting glass pestle can be used manually to disrupt tissue 
suspensions and obtain single cells or subcellular fragments without disrupting the nuclei.   
 
 
Figure 3 - Dounce Homogenizer.  This is a digital image of the dounce homogenizer 
used for the ChIP assays performed.   
 
 Cells were transferred to a 15 mL conical tube and centrifuged at 5000 rpm (RCF 
2400) for 10 minutes at 4ºC to pellet the nuclei.  After removing the supernatant, the 
pellet was resuspended in 1.0 mL of digestion buffer.  This solution was pre-warmed to 
37ºC for 5 minutes.   
 A working enzymatic cocktail solution was prepared by diluting the provided 
enzymatic cocktail with 50% glycerol in dH2O to a final concentration of 200 U/mL.  For 
optimization, 0.075 µL of stock enzymatic cocktail solution and 7.425 µL of 50% 
glycerol were mixed to provide enough reagent for three reactions.  Three reactions were 
set up using 50 µL of chromatin and 2.5 µL of enzyme for 37ºC incubation at 5, 10 and 
15 minutes respectively.  Additionally, one reaction was set up using 50 µL and 2.5 µL of 
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dH2O, which was incubated at 37ºC for 10 minutes to serve as a control.  After the 
incubations had completed, 1 µL of ice-cold EDTA was added to each tube and then 
chilled on ice for 10 minutes to stop the reactions.  The sheared DNA samples were 
centrifuged at 14,500 rpm in a 4ºC micocentrifuge for 10 minutes so that the supernatant 
contained the chromatin could be collected.  This chromatin could either be stored at -
80ºC or the cross-links could be reversed immediately.  
Reverse cross-links and remove RNA.  Cross-links were reversed by adding      
150 µL dH2O, 8 µL 5M NaCl and 1 µL RNase to the DNA sheared samples.  After 
vortexing to mix, the tubes were incubated overnight at 65ºC.   
Treatment with proteinase K.  Lastly, a Proteinase K treatment was performed by 
adding 2 µL to each tube and then incubating at 42ºC for 1.5 hours in order to digest 
protein and remove contamination. The DNA was then run on a 1% agarose gel to 
determine the optimal shearing conditions.      
Optimizing Conditions.  After the different reaction times conditions were 
categorized as under-digested, over-digested or optimized digestion through a 
comparison with a gel provided in the manufacturer’s protocol.  The ChIP assay was then 
performed using the procedures above with only the optimized digestion time.   
ChIP assay 
Chromatin preparation for the ChIP reactions had some notable deviations when 
compared to the optimization procedure.  These are highlighted below in the 
corresponding sections.   
Six plates were grown to 70-80% confluency, three treated with aldosterone and 
three untreated to serve as a control.  Aldosterone treatment of the IMCD3 cells by 
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diluting 10 µL of 2.77 mM aldosterone into 15µL of 100 % ethanol.  12uL of this 
mixture was added to three plates, while three plates were treated with 12µL of 100% 
ethanol to serve as a control.  After rocking the plates back and forth to mix, an 
incubation at 37ºC for an hour was performed.   
During the cell scraping step, the cells from the three plates treated with 
aldosterone and those that were not were pipetted into two separate 15mL conical tube 
for centrifugation at 2500 rpm (720 RCF) at 4ºC. After removing the supernatant, the 
pellets were resuspended in 1.0 mL of digestion buffer as before, but additionally the 
buffer was supplemented with 5 µL of both PMSF and PIC in order to inhibit protease 
function.  Additionally, after douncing the cells and pelleting the nuclei, the nuclei were 
resuspended in 1 mL of lysis buffer supplemented with 5 µL of both PIC and PMSF. 
 The enzymatic shearing cocktail working solution was prepared for two reactions 
for the chromatin to be used in ChIP reactions, one for the aldosterone treated cells and 
one for the control.  This included 1 µL of stock enzyme and 99 µL of 50% glycerol.  To 
each of the prewarmed nuclei, 50 µL of the working stock was added to each of the pre-
warmed nuclei and then incubated at 37ºC for previously determined optimized time, 10 
minutes.  The reactions were stopped by adding 20 µL of EDTA followed by chilling on 
ice for 10 minutes.  These samples were centrifuged at 14,500 rpm in a 4ºC 
microcentrifuge for 10 minutes so that the supernatant, which contains the sheared 
chromatin, could be collected.   The sheared chromatin was stored in 250 µL aliquots at -
80ºC.     
Pre-clearing of chromatin.  Chromatin was pre-cleared with Protein G beads in 
order to reduce the non-specific background, which is commonly associated with ChIP.  
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The purpose of pre-clearing is to reduce the amount of non-specific binding to G protein 
beads.   Therefore, the DNA isolated is contaminated and not completely purified, but 
this step attempts to alleviate that intrinsic flaw.  For the pre-clearing reactions the 
following reagents were combined into two microcentrifuged tubes, one for aldosterone 
treated and one for the untreated, to be rotated at 4ºC for 1-2 hours: 100 µL chromatin, 
200 µL resuspended protein G beads, 118 µL ChIP IP buffer and 1 µL PIC.  This 
provides a sufficient amount of reagents for two ChIP reactions for each tube.  After 
rotation, the tubes were microcentrifuged for two minutes at 4,000 rpm and then placed 
on ice for two minutes to let the protein beads settle.  The supernatant, chromatin, was 
then transferred to a fresh tube and the rotation and microcentrifugation steps were 
repeated to ensure complete removal of beads.  From each of the pre-cleared chromatin 
samples, 10 µL was transferred to a microcentrifuge tube and stored at -20ºC to be used 
as input DNA for the PCR analysis.  This DNA does not go through the steps specific to 
the ChIP assay and thus functions as a positive control.      
Addition of antibodies to Pre-cleared Chromatin.  The antibody treatment was 
performed using anti-RNA pol antibody (upstate 05-623) in order to precipitate the RNA 
polymerase present at promoters. PCR will determine whether or not this includes the 
Per1 promoter, and therefore, if the aldosterone treatment induced binding of pol II to the 
promoter of the Per1 gene.   Antibody incubations were performed in the kit’s provided 
0.65 mL siliconized tubes.  From each sample, 170 µL of the pre-cleared chromatin was 
transferred to two tubes respectively.  Then, 2.5 µL of anti-RNA pol antibody was added 
to one tube for each sample and nothing was added to the remaining two to serve as 
negative controls.  These tubes were incubated overnight on a rotator at 4ºC.            
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Addition of Protein G to Antibody/Chromatin Mixture. Protein G beads, that bind 
the non-specific portion of the antibody used, were then added so that the antibody will 
attach, thereby making the complex heavier so centrifugation can precipitate out the 
desired DNA-protein-antibody-bead complex.  After performing the incubation, 100 µL 
of resuspended protein G beads were added to each of the four antibody/chromatin 
mixtures and then incubated on a rotator for 1.5 hours at 4ºC.         
Washing ChIP reactions.  A series of washing of the ChIP reactions was 
performed to remove any protein-DNA complexes not specifically attached to the G 
protein bead.  The following buffers were prepared: ChIP IP buffer, wash buffer 1, wash 
buffer 2 and wash buffer 3 (supplied and ready to use).   The ChIP IP buffer was prepared 
by adding 1.6 mL to 8 µL PIC.  For wash buffer 1, 6.4 µL PIC was added to 6.4 mL of 
wash buffer 1.   Wash buffer 2 was prepared by adding 1.6 µL PIC to 1.6 mL of wash 
buffer 2.  After prepared, each of the solutions were mixed and placed on ice.   
After the incubation, the tubes were centrifuged for two minutes at 4,000 rpm and 
then allowed to settle for thirty seconds in order to pellet the beads.  After removing the 
supernatant, 400 µL of ChIP IP buffer was added to each of the tubes, then vortexed and 
incubated on a rotator for one to three minutes.  After pelleting the beads as stated above, 
beads were washed four times with 400 µL wash buffer 1; buffer was removed after each 
wash.  Next, the samples were washed with 400 µL of wash buffer 2, beads were pelleted 
and then washed with wash buffer 3.  After this final wash, as much buffer as possible 
was removed without disturbing the beads.       
DNA elution from Protein G.  DNA elution from protein G beads was performed 
in order to collect the immunoprecipitated DNA.  This was performed using 50 µL of 
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ChIP elution buffer, which was prepared by adding 20 µL 1M NaHCO3 to 400 µL of 
1%SDS.  After the addition of the elution buffer the tubes were vortexed and incubated 
for 15 minutes on a rotator at room temperature.  Next, tubes were centrifuged at 4,000 
rpm to pellet the beads and then the supernatant was transferred to microcentrifuge tubes.     
Reverse cross-links and remove RNA.  In addition to the ChIP elutions from 
above, the input DNA was also taken through the following steps of reversing the cross-
links and removing RNA, which differ in the amount of reagents used from the same 
procedure for optimization.  To each ChIP elution and the two input DNA samples 4 µL 
of 5 M NaCl and 1 µL RNase A was added and then mixed completely and centrifuged 
briefly.  These tubes were incubated at 65ºC overnight.   
Treatment with proteinase K. After overnight incubation, these samples were 
treated with proteinase K in order to digest protein and remove additional contaminants.  
This section is slightly different from the optimization portion of this procedure; the 
following three components were added to each tube: 2 µL 0.5 M EDTA, 2 µL 1M Tris-
Cl pH 6.5, and 2 µL proteinase K solution.  After vortexing to mix and a short 
centrifugation the tubes were incubated at 42ºC for two hours to be followed by DNA 
purification.         
Purification of eluted DNA. Following incubation, 500 µL of DNA binding buffer 
was added to the proteinase K treated samples.  Each of these samples were then 
transferred into respectively labeled DNA purification mini-columns and then centrifuged 
for 30 seconds at 14,500 rpm.  After discarding the flow-through, 600 µL of DNA wash 
buffer was added to each mini-column and centrifugation for thirty seconds at 14,500 was 
performed.  After removing this flow-through, 300 µL of DNA wash buffer was added 
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and centrifugation at 14,500 rpm was performed for two minutes.  Then each of the mini-
columns was placed in a microcentrifuge collecting tube and 50 µL of DEP-C treated 
H2O was added directly to the resin of each mini-column.  After incubation for three 
minutes at room temperature these samples were centrifuged at 14,500 rpm for one 
minute.  This was repeated and then the eluted DNA was either stored at -20ºC or used 
for PCR analysis.      
PCR Analysis.  PCR was performed as previously described in the testing primers 
section.  By amplifying the DNA it will be possible to detect if Per1 was precipitated 
using the RNA pol antibody that was immunoprecipitated by the ChIP procedure making 
it apparent whether or not aldosterone regulated Per1 at the transcriptional level.  If any 
of the proteins recognized by the specific antibody used were bound to the Per1 
promoter, then the Per1 promoter should be amplified.    
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R E S U L T S  
 Designing Primers.  Using the criteria discussed in the methods section both a 
forward and reverse primer for each set were successfully designed and are shown in 
Table 2.  
Table 2 - Primers for Set 3 and Set 6    
 Set 3 Set 6 
Forward 
Primer 
ATAGGAGGCGATCAGCTCACC 
(1504-1524) 
GCCTCTAGCTTCTTAGCAGAGTGG 
(4265-4288) 
Reverse 
Primer 
GCTGTACTCATTCCACACTGGCAA 
(1635-1658) 
TTGGGAGAGACAGCTCACTCT 
(4445-4465) 
 
 Spectrophotometric Analysis of DNA Samples.  After transformation, isolations 
and DNA purification the Per1 and pMLG107 DNA samples were tested for 
concentration and purity using a spectrophotometer.  The results for each plasmid are 
shown in Table 3.   
Table 3 – Spectrophotometric Analysis of Primers 
 Absorbance 260nm 
(A) 
Absorbance 280nm 
(A) 
[DNA] 
ng/µL 
Purity 
per1 0.249 0.131 311 1.90 
pMLG107 0.248 0.132 310. 1.88 
 
Restriction Enzyme Digest.  The expected results for both the pMLG and pPer1 
plasmids were not obtained after multiple restriction enzyme digests, but Figure 4C is 
representative of the results obtained.  In the case of the pMLG plasmid, its digestion 
with BAMHI and HindIII is shown in Lanes 2 and 4 respectively.  There are more 
products than expected in Lane 2, but the ~4,000, ~3,000, and ~400bp fragments are 
represented on the gel.  In Lane 4, the expected bands of ~6,000 and ~500bp were visible, 
but an additional band of ~3,000bp was present as well.  For the digestion of pPer1with 
SalI, represented in Lane 5, bands of ~4,000 and ~5,000bp were visible as predicted.   
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Figure 4 – Restriction Enzyme Digest for Per1 and pMLG107.  4A shows the 
restriction enzyme digest for the pPer1 plasmid using SalI.  SalI cuts the Per1 insert at 
base pair 4 and at 120 in the vector.  This results in fragment sizes of 4797bp and 4280bp.  
4B shows the digest for the pMLG107 plasmid when using BamhI and HindIII.  BamHI 
cuts the insert at 8 and 374, while HindIII cuts at 1595.   In the vector the enzymes cut at 
595 and 2004 respectively.  This results in fragment sizes of 3632, 2822 and 366bp.  4C 
shows the gel that was performed after the RE digest.  Lane 1 and 3 were empty, but 
some spilling over occurred into Lane 3.  Lane 2 represents the digestion of pMLG with 
BAMHI, while Lane 4 represents the digestion with HindIII.  Lane 5 represents the 
digestion of pPer1 with SalI.  The 200bp molecular marker is indicated by “M,” and the 
respective fragments sizes are shown on the left.     
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Amplification Using Set 3 and Set 6 Primers on pPer1 and pMLG107.  For both 
the Set 3 and Set 6 primers the expected products were visible on the gel shown in Figure 
5.  For pMLG with Set 3 primers the final product was expected to be 154bp, which did 
appear on the gel in Lane 1 and 4.  Set 3A and Set 3 B represent primers two sets of the 
similar primers, synthesized at different times to avoid contamination, which was 
previously a problem.  The 200bp product was also shown in Lane 9 for the Set 6 primers 
used with pPer1.  Therefore, both Set 3 primers yielded the expected ~150bp product in 
the pMLG lanes (1 & 4), while the Set 6 primers yielded the ~200bp in the pPer1 lane 
(9).  There were no bands in the control lanes with dH20.                           
~100
200
 
Figure 5 – PCR of pPer1 and pMLG107 Using Set 3 and Set 6 Primers.  Lane 1,2 & 
3 represent Set 3A primers with pMLG, pPer1, and dH20 respectively.  Lane 4,5 & 6 
represent Set 3B primers with pMLG, pPer1, and dH20 respectively.  Lane 8, 9 & 10 
represent Set 6 primers with pMLG, pPer1, and dH20 respectively.  Lanes 7 & 11 were 
empty.  The 100bp molecular marker is indicated by “M,” and the respective fragments 
sizes are shown on the left.   
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Chromatin Immunoprecipiation (ChIP) 
Enzymatic Shearing Optimization.  Enzymatic shearing was performed on three 
samples of DNA for varying amounts of time and then the products were run on a gel as 
shown in Figure 6.                 
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Figure 6 – Enzymatic Shearing Optimization.  Lane 2 was empty.  Lane 3 represents 
unsheared DNA.  Lane 4 represents DNA treated for 5 minutes, which is under-digested.  
Lane 5 represents DNA treated for 10 minutes, which is optimized digestion.  Lane 6 
represents DNA treated for 15 minutes, which is over-digested.  The 100bp molecular 
marker is indicated by “M,” and the respective fragments sizes are shown on the left.       
 
Amplification of ChIP Assay Products.  After the entire ChIP protocol was 
performed, PCR with primers sets three and six was performed and then the products 
were run on a gel as shown in Figures 7A and B.  Bands appeared as expected for the 
plasmids; however, no bands were obtained in any of the ChIP products, including the 
input DNA samples.       
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Figure 7– PCR with Set 3 & Set 6 After ChIP Assay.  Gel A shows the results of using 
Set 3 primers, while Gel B shows the results of using Set 6 primers.  The lanes for each 
respective gel are the same samples.  Lane 1 was empty in both gels.  Lanes 2 & 3 
represent pMLG and pPer1 respectively. Gel A shows the expected ~150bp product for 
pMLG, while Gel B shows the expected ~200bp for pPer1.  Lanes 4 & 5 represent the 
input DNA for the aldosterone-treated cells and the control cells respectively.  Lanes 6 is 
the DNA for the aldosterone-treated cells, which received the antibody treatment, while 
Lane 7’s cells did not.  Lane 8 is the control cells, which received the antibody treatment, 
while Lane 9’s cells did not.  Lanes 4-9 did not show any bands, but have smudges at the 
bottom indicating unused primers.  The 100bp molecular markers are indicated by “M,” 
and the respective fragments sizes are shown on the left.         
 
Amplification of ChIP Assay Products without Pre-clearing or Antibody 
treatment, “Mock” ChIP.  In an attempt to obtain results consistent with the expectations, 
PCR was run on products that were sheared, had cross-links reversed, treated with 
proteinase K, and purified.  These products did not go through the pre-clearing or 
antibody treatment steps.  Figure 8 shows the results of the PCR on a gel, which includes 
the expected product for the aldosterone treated cells for both Set 3 and Set 6 primers.  
Control cells only showed the expected 200bp product for Set 6 primers.   
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Figure 8 – PCR with Sets 3 & 6 “Mock” ChIP Assay; No Pre-clearing or Antibody 
treatment performed.  Lane 1 was empty.  Lane 2 & 3 represent input DNA for 
aldosterone treated cells using Set 3 & 6 respectively.  Lane 4 & 5 represent control cells 
using Set 3 & 6 respectively. Each of these samples underwent a “Mock” ChIP, which 
includes reverse cross-linking, removal of RNA, proteinase K treatment and purification.  
The 100bp molecular markers are indicated by “M,” and the respective fragments sizes 
are shown on the left.           
29 
D I S C U S S I O N  
  
Since there were no products visualized on the gel for the ChIP products that 
underwent PCR amplification results were inconclusive and it could not be determined 
whether or not the aldosterone-receptor complex was bound to the Per1 promoter 
element.  This is likely due to DNA loss that occurred in one of the ChIP assay steps, 
potentially the pre-clearing of chromatin step.   
The primers created for the purposes of this study were consistent with the criteria 
ideal for ChIP samples.  Set 3 represents the location where it is hypothesized that the 
aldosterone receptor binds and if this occurs in actuality, ChIP should confirm with a 
band of 154bp after PCR analysis of the products.  Set 6 represents a control set that 
maximized the distance from the -156GRE region so that the aldosterone receptor would 
not bind in that region.  This negative control should not result in precipitation of the 
fragments present at the promoter because the protein of interest, the aldosterone 
receptor, should not be bound to that region.  After ChIP, these products should show a 
band of 200bp after PCR analysis.  Before the designed primers were used on plasmids 
pMLG and pPer1, their respective concentrations and purities were determined using 
spectrophotometric analysis. 
   The DNA concentrations for pMLG and pPer1 were calculated to be 311 and 
310 ng/µL respectively.  Typically, a good quality DNA sample has a purity ratio of 1.7-
2.0, which includes the determined values of 1.90 and 1.88 as shown in Table 2.  Another 
method used to test the plasmids before the primers were used was the restriction enzyme 
digests.   
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Three separate restriction enzyme digests were performed in order to obtain 
results consistent with the restriction digest maps shown in Figures 4A and B.  The gel 
depicted in Figure 4C is representative of these results and shows a successful digest for 
the pPer1 plasmid using SalI, which includes the expected 4797bp and 4280bp fragments.  
For pMLG two separate enzymes were used to try and obtain predicted results, but for 
each digest additional bands were present in on the gels.  The reason for the discrepancies 
of the restriction enzyme digest were not investigated since the PCR on the plasmids 
verified both the primer design and the presence of the appropriate fragment within each 
plasmid (Figure 5).   
In order to start the ChIP protocol tissue culture conditions and enzymatic 
shearing conditions were optimized.  The aldosterone treatment was performed for an 
hour before starting the cell fixation step.  It is important to note that using the proper 
dounce homogenizer results in a drastic increase in the amount of DNA available for 
shearing.  This is due to its gentle lysing nature, which aids in releasing intact nuclei.         
Using the guidelines of the ChIP-It protocol, the results of Figure 6 were analyzed 
to best determine the optimal time for shearing for the ChIP assays.  Upon comparison to 
a provided figure in the procedure, it was apparent that five minutes resulted in under-
digestion of the DNA and that fifteen minutes resulted in the over-digestion.  Ten 
minutes was determined to be the optimized time for digestion to use when completing 
the entire ChIP procedure.   
  After digesting the DNA sheared from the tissue cultured cells for the optimized 
time, these ChIP samples were taken through the entire protocol.  The gel of the PCR 
products are shown in Figures 7A and B.  The only bands that appeared were for the 
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respective plasmids and their primer sets (pMLG, Set 3 and pPer1, Set 6).  These results 
were particularly unexpected because no bands appeared in the input DNA lanes, which 
represent genomic DNA prior to any precipitation. These samples traditionally serve as a 
positive control for PCR effectiveness and should have a band regardless of the 
treatment.  These samples were not taken through the pre-clearing and antibody treatment 
steps.  Since the positive control in this experiment was unsuccessful, the remainder of 
the results were uninterpretable.  In order to discover a reason for this discrepancy, 
previously saved aliquots from DNA shearing were taken through a “mock ChIP” 
procedure that did not include the pre-clearing and antibody steps to determine the 
possibility of DNA loss in one of the steps.   
As shown in Figure 8, the input DNA from the “mock ChIP” did in fact show the 
expected bands for both the primer sets regardless of aldosterone treatment, suggesting 
that an error occurred early in the actual ChIP experiment.  The lack of a band in the lane 
representing the control cells with Set 3 primers in addition to the faint band in the lane 
for the aldosterone-treated cells with Set 3 indicate that perhaps the PCR conditions for 
Set 3 need to be adjusted to obtain better results.  These results, combined with the lack 
of product in the ChIP PCR gel in Figures 7A and B suggest that DNA loss likely 
occurred in the pre-clearing step.  
For future study, a systematic approach to determine if either the pre-clearing or 
antibody treatment steps result in DNA loss, should be performed.  It is likely that DNA 
loss occurred during the pre-clearing, because input DNA from the same aliquot was used 
in the “mock” ChIP (without pre-clearing) and results were obtained as shown in Figure 
8.  By testing the samples at different stages of the ChIP protocol any possible error could 
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potentially be pinpointed to a specific step.  If successful in that analysis, this part of the 
procedure could be better examined to ensure that DNA is maintained in the samples.   
Overall, this research project has been a success in that it has set the stage for 
continued research concerning the proposed mechanism of aldosterone regulated Per1 
circadian regulation of hypertension.  Primers were successfully designed and tested for 
both the pMLG and pPer1 plasmid confirming their identities.  Tissue culture conditions 
were successfully documented and the appropriate aldosterone treatment procedure was 
determined.  Additionally, the optimized digestion time for enzymatic shearing of the 
chromatin was determined to be ten minutes.  The initial steps of the ChIP protocol were 
shown to be successful on the samples.  The collected data and procedural notes provides 
the backbone for the future success of this research project’s original goal to verify the 
binding of aldosterone and its receptor to the Per1 promoter in order to potentially 
regulate circadian blood pressure patterns.    
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